iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Wesley Jong; JGJV Aerts; S Allard; C Brander; J Buyze; E Florence; B Mothe; J Martinez-Picado; A Olvera; M Rosas; M Salgado; S Moron; J Molto; M Lopez; A Graupera; A Honrado

doi:10.1186/s13063-019-3409-1

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Wesley Jong, JGJV Aerts, S Allard, C Brander, J Buyze, E Florence, B Mothe, J Martinez-Picado, A Olvera, M Rosas, M Salgado, S Moron, J Molto, M Lopez, A Graupera, A Honrado

Virology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

9 Downloads (Pure)

Original language	Undefined/Unknown
Article number	361
Journal	Trials
Volume	20
DOIs	https://doi.org/10.1186/s13063-019-3409-1
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13063-019-3409-1

Repub_117419_O-A.pdfFinal published version, 1.07 MB

http://hdl.handle.net/1765/117419

Cite this

Jong, W., Aerts, JGJV., Allard, S., Brander, C., Buyze, J., Florence, E., Mothe, B., Martinez-Picado, J., Olvera, A., Rosas, M., Salgado, M., Moron, S., Molto, J., Lopez, M., Graupera, A., & Honrado, A. (2019). iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy. Trials, 20, Article 361. https://doi.org/10.1186/s13063-019-3409-1

@article{bce87903d662493394bc2f6790b76c0c,

title = "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy",

author = "Wesley Jong and JGJV Aerts and S Allard and C Brander and J Buyze and E Florence and B Mothe and J Martinez-Picado and A Olvera and M Rosas and M Salgado and S Moron and J Molto and M Lopez and A Graupera and A Honrado",

year = "2019",

doi = "10.1186/s13063-019-3409-1",

language = "Undefined/Unknown",

volume = "20",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

}

Jong, W, Aerts, JGJV, Allard, S, Brander, C, Buyze, J, Florence, E, Mothe, B, Martinez-Picado, J, Olvera, A, Rosas, M, Salgado, M, Moron, S, Molto, J, Lopez, M, Graupera, A & Honrado, A 2019, 'iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy', Trials, vol. 20, 361. https://doi.org/10.1186/s13063-019-3409-1

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy. / Jong, Wesley; Aerts, JGJV; Allard, S et al.
In: Trials, Vol. 20, 361, 2019.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

AU - Jong, Wesley

AU - Aerts, JGJV

AU - Allard, S

AU - Brander, C

AU - Buyze, J

AU - Florence, E

AU - Mothe, B

AU - Martinez-Picado, J

AU - Olvera, A

AU - Rosas, M

AU - Salgado, M

AU - Moron, S

AU - Molto, J

AU - Lopez, M

AU - Graupera, A

AU - Honrado, A

PY - 2019

Y1 - 2019

U2 - 10.1186/s13063-019-3409-1

DO - 10.1186/s13063-019-3409-1

M3 - Article

SN - 1745-6215

VL - 20

JO - Trials

JF - Trials

M1 - 361

ER -